Quinidine gluconate
NDC 71930-016, Quinidine gluonate, tablet, extended release, from Eywa Pharma Inc.
- Product NDC
- 71930-016
- Status
- Listed
- Labeler
- Eywa Pharma Inc
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212589
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71930-016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- QUINIDINE GLUCONATE324 mg/1
Pharmacologic classes
Antiarrhythmic [EPC]; Cytochrome P450 2D6 Inhibitor [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71930-016-12 | 71930001612 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71930-016-12) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4db375a3-0cff-4fa7-af7a-2a49e0b922d0NADAC price for package 71930001612
GET /v1/drugs/nadac/71930001612
Use it
Look up 71930-016 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71930-016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71930-016. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.